Agile patents expiration

1. Twirla patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8747888 AGILE Dermal delivery device with in situ seal
Jul, 2028

(4 years from now)

US9050348 AGILE Dermal delivery device
Jul, 2028

(4 years from now)

US8246978 AGILE Dermal delivery device with reduced loss of its volatile components
Aug, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Feb 14, 2023

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 14 February, 2020

Treatment: NA


More Information on Dosage

TWIRLA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic